30 results
8-K
EX-99.1
ELAN
Elanco Animal Health Inc
7 Nov 23
Elanco Animal Health Reports Third Quarter 2023 Results
6:29am
and Japan.
Launched Varenzin™-CA1, the first-of-its-kind oral treatment for anemia in cats with chronic kidney disease after receiving FDA conditional
8-K
EX-99.1
ELAN
Elanco Animal Health Inc
9 May 23
Elanco Animal Health Reports First Quarter 2023 Results
6:34am
for the control of non-regenerative anemia associated with chronic kidney disease (CKD) in cats.
In the U.S., launched Bexacat™, a first-in-class once
8-K
EX-99.1
ELAN
Elanco Animal Health Inc
5 Oct 21
Elanco Announces New Innovation Leader, Additional Strategic Move to Increase Focus on High-Value, Late-Stage Pet Health Pipeline Progress
6:36am
as a number of additional R&D programs in sizeable and growing pet health markets like parasiticides, pain, and biologicals, as well as for other chronic
8-K
EX-99.1
ELAN
Elanco Animal Health Inc
30 Aug 21
Elanco Closes Acquisition of Kindred Biosciences
9:01am
for other chronic disorders and unmet needs. The transaction also builds on the existing relationship between Elanco and KindredBio, including the prior
DFAN14A
ELAN
Elanco Animal Health Inc
16 Jun 21
Additional proxy materials by non-management
4:30pm
across the combined portfolio. Three of which are expected to come from KindredBio. The deal also brings additional shots on goal for other chronic … potential to address the need for both acute and chronic disease. There are some acute indications like flea bites or seasonal allergies
DFAN14A
zce k7un1qd
16 Jun 21
Additional proxy materials by non-management
7:08am
8-K
EX-99.2
6ky8dgdrlj2dtcr5w
16 Jun 21
Elanco Announces Agreement to Acquire Kindred Biosciences
7:01am
8-K
EX-99.1
zrp qwerli
16 Jun 21
Elanco Announces Agreement to Acquire Kindred Biosciences
7:01am
8-K
EX-99.1
vaosfhd43uo0jusoz
7 May 21
Elanco Animal Health Reports First Quarter 2021 Results
6:42am
8-K
EX-99.1
k1d68qse1qafcs58
6 Nov 20
Elanco Animal Health Reports Third Quarter 2020 Results
6:39am
424B5
e8q qynh47
24 Jan 20
Prospectus supplement for primary offering
4:49pm
424B5
b7lci0
24 Jan 20
Prospectus supplement for primary offering
4:44pm
424B5
oi7hp0ub2m
21 Jan 20
Prospectus supplement for primary offering
4:51pm
424B5
0smccvsrnqk0puu1
21 Jan 20
Prospectus supplement for primary offering
4:48pm
424B3
g33hb
17 Jun 19
Prospectus supplement
6:55am
424B3
zzm0q2b5u db0m31x
29 May 19
Prospectus supplement
4:06pm
425
gnwqtxm34ai
26 Apr 19
Business combination disclosure
5:31pm